机器人辅助与电视辅助胸腔镜解剖性肺切除的远期与近期结局:系统综述与荟萃分析
RATS组无病生存优于VATS组(HR 0.76,95%CI 0.59-0.97,P=0.03),总生存呈相似趋势但无统计学意义,30天死亡率显著更低(OR 0.55,95%CI 0.38-0.81,P=0.002),术后并发症、中转开胸率及淋巴结升级无显著差异。
要点
- RATS组无病生存优于VATS组,HR 0.76(95%CI 0.59-0.97,P=0.03)。
- RATS组30天死亡率显著低于VATS组,OR 0.55(95%CI 0.38-0.81,P=0.002)。
- 两组术后并发症、中转开胸率及淋巴结升级均无显著差异。
核心结论
- 与VATS相比,RATS用于解剖性肺切除的近期结局相当,并可能具有远期生存获益。
研究设计与样本
- 比较远期结局(无病生存、总生存)与近期结局(30天死亡率、术后并发症、中转开胸率、淋巴结升级),效应量以HR和OR及95%CI表示。
主要发现
- RATS组无病生存长于VATS组(HR 0.76;95%CI 0.59-0.97;P=0.03)。
- 总生存呈相似趋势但无统计学意义(HR 0.77;95%CI 0.57-1.05;P=0.10)。
- RATS组30天死亡率显著更低(OR 0.55;95%CI 0.38-0.81;P=0.002)。
- 术后并发症(OR 1.01;95%CI 0.87-1.16;P=0.94)、中转开胸率(OR 0.92;95%CI 0.56-1.52;P=0.75)及淋巴结升级(OR 0.89;95%CI 0.52-1.54;P=0.68)均无显著差异。
临床怎么用
- 在解剖性肺切除中,RATS可作为与VATS相当的微创选择,并可能带来无病生存获益与更低的30天死亡率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Minimally invasive thoracic surgery has evolved with the introduction of robotic platforms. This study aimed to compare the long-term and short-term outcomes of the robot-assisted thoracic surgery (RATS) and video-assisted thoracic surgery (VATS) for anatomic lung resection. METHODS: We searched published studies that investigated RATS and VATS in anatomic lung resection. Long-term outcomes (disease-free survival and overall survival) and short-term outcomes (30-day mortality, postoperative complications, conversion rate to open surgery and lymph node upstaging) were extracted. The features were compared and tested as hazard ratios (HRs) and odds ratios (ORs) at a 95% confidence interval (CI). RESULTS: Twenty-five studies with 50 404 patients (7135 for RATS and 43 269 for VATS) were included. The RATS group had a longer disease-free survival than the VATS group (HR: 0.76; 95% CI: 0.59-0.97; P = 0.03), and the overall survival showed a similar trend but was not statistically significant (HR: 0.77; 95% CI: 0.57-1.05; P = 0.10). The RATS group showed a significantly lower 30-day mortality (OR: 0.55; 95% CI: 0.38-0.81; P = 0.002). No significant difference was found in postoperative complications (OR: 1.01; 95% CI: 0.87-1.16; P = 0.94), the conversion rate to open surgery (OR: 0.92; 95% CI: 0.56-1.52; P = 0.75) and lymph node upstaging (OR: 0.89; 95% CI: 0.52-1.54; P = 0.68). CONCLUSIONS: RATS has comparable short-term outcomes and potential long-term survival benefits for anatomic lung resection compared with VATS.
引用
- Wu H, Jin R, Yang S, et al. Long-term and short-term outcomes of robot- versus video-assisted anatomic lung resection in lung cancer: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2021. PMID: 33367615. doi:10.1093/ejcts/ezaa426
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。